Low-abundance drug resistance mutations: extending the HIV paradigm to hepatitis B virus

J Infect Dis. 2009 Dec 1;200(11):1798-9; author reply 1799-1800. doi: 10.1086/647991.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / pharmacology*
  • DNA, Viral / genetics
  • Drug Resistance, Viral
  • HIV / drug effects
  • HIV / genetics*
  • HIV Infections / drug therapy
  • HIV Infections / virology
  • Hepatitis B / drug therapy
  • Hepatitis B / virology
  • Hepatitis B virus / drug effects
  • Hepatitis B virus / genetics*
  • Humans
  • Mutation*

Substances

  • Antiviral Agents
  • DNA, Viral